In this online, self-learning activity:
Influenza has been recognized as a global public health menace since at least 100 years ago with the 1918-19 pandemic, which infected an estimated one-third of the world’s population and was responsible for the deaths of one in ten, or 50 million, of those infected. While some have contended that a significant number of deaths associated with the 1918 pandemic may have actually been attributable to acid-base derangements and pulmonary edema associated with contemporary aspirin dosing in the toxic range of two to eight times what is presently the maximum recommended dose – it remains a significant public health concern, with the 2017-2018 flu season in recent decades with an estimated 80,000 deaths (typical range 12,000-56,000 per year),coming with an annual cost of $16 billion.
Healthcare professionals specializing in: infectious disease, internal medicine, and pediatrics; physician assistants, nurse practitioners, nurses, and pharmacists who specialize in the aforementioned areas; and any other healthcare professionals with an interest in or who clinically encounter patients with influenza.
This program is supported by an educational grant from Sanofi Pasteur.
This activity is free of charge.
Release Date: July 23, 2019 -- Expiration Date: July 23, 2021
Faculty: Diane Birnbaumer, MD
Faculty introduction, disclosures
Epidemiology of and risk factors for acquiring influenza
Pathogenesis and prevention of influenza
Barriers to care and how to best address them
Summary, conclusions, and best practice recap
By the end of the session the participant will be able to:
ACCME Activity #201336514ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.
Faculty Disclosure: Diane Birnbaumer, MD, has no relevant conflicts of interest to disclose.
Disclosures of Educational Planners: Charles Turck, PharmD, BCPS, BCCCP, CEO of ScientiaCME, has no relevant conflicts of interest to disclose.
Commercial Support Disclosure: This program is supported by an educational grant from Sanofi Pasteur
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.
Novel antimicrobials and infectious disease practice: Research updates from ID Week 2019
Updates in vaccine-preventable diseases: Meningococcal meningitis
The problem with vaccines: Public hesitancy and refusal
Coronavirus disease 2019 (COVID-19) preparedness, facts, and management